Insights

Recent Acquisitions Genmab has recently acquired ProfoundBio, a biotech firm specializing in cancer treatments, for $1.8 billion. This acquisition opens up opportunities to cross-sell Genmab's existing antibody medicines alongside ProfoundBio's products.

Expansion into the U.S. Genmab has expanded its offices in the United States and is planning to hire 300 new employees. This expansion signifies a growing presence in the U.S. market, presenting opportunities for local sales and partnerships.

Financial Investment Royal London Asset Management has made a significant investment of $8.94 million into Genmab. This vote of confidence in Genmab's potential opens doors for potential collaborations and joint ventures with the financial institution.

Market IPO Genmab recently went public, indicating a strong market presence and potential for increased investor interest. This IPO can lead to enhanced visibility and credibility, attracting new business opportunities.

Technology Adoption Genmab utilizes a range of cutting-edge technologies in its operations, including Blockchain and Amazon Web Services. Leveraging these technologies can provide a competitive edge, appealing to tech-savvy clients and driving sales through innovation.

Genmab Tech Stack

Genmab uses 8 technology products and services including Visual Website Optimizer, Blockchain, Amazon S3, and more. Explore Genmab's tech stack below.

  • Visual Website Optimizer
    Analytics
  • Blockchain
    Blockchain
  • Amazon S3
    Content Delivery Network
  • Microsoft Outlook
    Email
  • Backbone.js
    Javascript Frameworks
  • Vyond
    Marketing
  • Cisco
    Network Hardware
  • Amazon Web Services
    Platform As A Service

Media & News

Genmab's Email Address Formats

Genmab uses at least 1 format(s):
Genmab Email FormatsExamplePercentage
f.last@genmab.comJ.Doe@genmab.com
62%
firstl@genmab.comJohnD@genmab.com
20%
filast@genmab.comJoDoe@genmab.com
10%
first.last@genmab.comJohn.Doe@genmab.com
8%

Frequently Asked Questions

Where is Genmab's headquarters located?

Minus sign iconPlus sign icon
Genmab's main headquarters is located at Kalvebod Brygge 43 Copenhagen V, DK-1560 DK. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Genmab's phone number?

Minus sign iconPlus sign icon
You can contact Genmab's main corporate office by phone at +1-609-430-2481. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Genmab's stock symbol?

Minus sign iconPlus sign icon
Genmab is a publicly traded company; the company's stock symbol is GMAB.

What is Genmab's official website and social media links?

Minus sign iconPlus sign icon
Genmab's official website is genmab.com and has social profiles on LinkedIn.

How much revenue does Genmab generate?

Minus sign iconPlus sign icon
As of July 2024, Genmab's annual revenue reached $750M.

What is Genmab's SIC code NAICS code?

Minus sign iconPlus sign icon
Genmab's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genmab have currently?

Minus sign iconPlus sign icon
As of July 2024, Genmab has approximately 2.5K employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer: A. P.Vice President Oncology Clinical Development: I. S.Vice President And Head, Us Medical Affairs: S. G.. Explore Genmab's employee directory with LeadIQ.

What industry does Genmab belong to?

Minus sign iconPlus sign icon
Genmab operates in the Biotechnology Research industry.

What technology does Genmab use?

Minus sign iconPlus sign icon
Genmab's tech stack includes Visual Website OptimizerBlockchainAmazon S3Microsoft OutlookBackbone.jsVyondCiscoAmazon Web Services.

What is Genmab's email format?

Minus sign iconPlus sign icon
Genmab's email format typically follows the pattern of . Find more Genmab email formats with LeadIQ.

How much funding has Genmab raised to date?

Minus sign iconPlus sign icon
As of July 2024, Genmab has raised $134M in funding. The last funding round occurred on Jul 01, 2010.
Genmab

Genmab

Biotechnology ResearchCopenhagen V, Denmark1001-5000 Employees

We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab you'll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing biotechnology company. Genmab is a place where you can be authentically you; you are empowered to innovate, build solutions and execute; you feel cared for and supported. In its totality, this makes working at Genmab an extra[not]ordinaryTM  experience. Established in 1999, we are headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com.  
Disclaimer: http://bit.ly/GENDisclaimer 

Section iconCompany Overview

Headquarters
Kalvebod Brygge 43 Copenhagen V, DK-1560 DK
Phone number
+1-609-430-2481
Website
genmab.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
GMAB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $134M

    Genmab has raised a total of $134M of funding over 5 rounds. Their latest funding round was raised on Jul 01, 2010.

  • $100M$1B

    Genmab's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $134M

    Genmab has raised a total of $134M of funding over 5 rounds. Their latest funding round was raised on Jul 01, 2010.

  • $100M$1B

    Genmab's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.